Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.
Charnalia M, Chopra S, Mulani J, Popat P, Rath S, Thomeer M, Mittal P, Gupta A, Boere I, Gupta S, Nout RA. Charnalia M, et al. Among authors: mulani j. Int J Gynecol Cancer. 2024 Apr 22:ijgc-2024-005336. doi: 10.1136/ijgc-2024-005336. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38649234
Transitioning India to advanced image based adaptive brachytherapy: a national impact analysis of upgrading National Cancer Grid cervix cancer guidelines.
Hande V, Chopra S, Polo A, Mittal P, Kohle S, Ghadi Y, Mulani J, Gupta A, Kinhikar R, Agarwal JP. Hande V, et al. Among authors: mulani j. Lancet Reg Health Southeast Asia. 2023 Jun 6;16:100218. doi: 10.1016/j.lansea.2023.100218. eCollection 2023 Sep. Lancet Reg Health Southeast Asia. 2023. PMID: 37694176 Free PMC article.
Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
Chopra S, Mulani J, Mittal P, Singh M, Shinde A, Gurram L, Scaria L, Aravindakshan D, Kohle S, Rane P, Ghadi Y, Rath S, Ghosh J, Gulia S, Gupta S, Kinhikar R, Laskar S, Agarwal JP. Chopra S, et al. Among authors: mulani j. Brachytherapy. 2023 Mar-Apr;22(2):125-131. doi: 10.1016/j.brachy.2022.10.006. Epub 2022 Nov 2. Brachytherapy. 2023. PMID: 36585283 Free PMC article.
Salvage (Re)radiation in Oligometastatic and Oligorecurrent Cervical Cancer.
Chopra S, Kalra B, Mulani J, Jain J, Gurram L, Mittal P, Alone M, Ghosh J, Rath S, Gulia S, Gupta S. Chopra S, et al. Among authors: mulani j. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):812-819. doi: 10.1016/j.ijrobp.2022.07.002. Epub 2022 Jul 16. Int J Radiat Oncol Biol Phys. 2022. PMID: 35850364
Shorter Treatment for Tuberculosis in Children.
Mishra G, Mulani J. Mishra G, et al. Among authors: mulani j. N Engl J Med. 2022 Jun 23;386(25):2439. doi: 10.1056/NEJMc2204561. N Engl J Med. 2022. PMID: 35731666 No abstract available.
Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial.
Chopra S, Goda JS, Mittal P, Mulani J, Pant S, Pai V, Kannan S, Deodhar K, Krishnamurthy MN, Menon S, Charnalia M, Shah S, Rangarajan V, Gota V, Naidu L, Sawant S, Thakkar P, Popat P, Ghosh J, Rath S, Gulia S, Engineer R, Mahantshetty U, Gupta S. Chopra S, et al. Among authors: mulani j. BMJ Open. 2022 Apr 6;12(4):e055765. doi: 10.1136/bmjopen-2021-055765. BMJ Open. 2022. PMID: 35387819 Free PMC article.
Patterns of Relapse After Adjuvant Chemoradiation for Cervical Cancer in a Phase 3 Clinical Trial (PARCER): An Evaluation of Updated NRG Oncology/RTOG Target Delineation Guidelines.
Mittal P, Chopra S, Charnalia M, Dora T, Engineer R, Mulani J, Scaria L, Prajapati K, Kannan S, Gurram L, Mahantshetty U, Gupta S, Shrivastava SK. Mittal P, et al. Among authors: mulani j. Int J Radiat Oncol Biol Phys. 2022 Jun 1;113(2):369-378. doi: 10.1016/j.ijrobp.2022.02.007. Epub 2022 Feb 12. Int J Radiat Oncol Biol Phys. 2022. PMID: 35157993 Clinical Trial.
Implications of bedaquiline-resistant tuberculosis.
Mishra GP, Mulani J. Mishra GP, et al. Among authors: mulani j. Lancet Infect Dis. 2022 Feb;22(2):166. doi: 10.1016/S1473-3099(22)00007-X. Lancet Infect Dis. 2022. PMID: 35092790 No abstract available.
14 results